Insulin assay standardization: Leading to measures of insulin sensitivity and secretion for practical clinical care - Response to Heinemann

Diabetes Care

Volumn 33, Issue 6, 2010, Pages

  Staten, Myrlene A ^a   Miller, W Greg ^b   Bowsher, Ronald R ^c   Steffes, Michael W ^d  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Millipore Corporation   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; RECOMBINANT HUMAN INSULIN;

BIOASSAY; BIOTRANSFORMATION; IMMUNOASSAY; INSULIN RELEASE; INSULIN SENSITIVITY; LETTER; MOLECULAR WEIGHT; STANDARDIZATION;

EID: 77957150948     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0478     Document Type: Letter

References (4)

1. Heinemann L. Insulin Assay Standardization: leading to measures of insulin sensitivity and secretion for practical clinical care: response to Staten et al (Letter). Diabetes Care 2010;33:e83. DOI: 10.2337/dc10-0034
2. Marcovina S, Bowsher RR, Miller WG, Staten M, Myers G, Caudill SP, Campbell SE, Steffes MW, Insulin Standardization Workgroup. Standardization of Insulin Immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 2007;53:711-716 (Pubitemid 46580242)
3. Miller WG, Thienpont LM, Van Uytfanghe K, Clark PM, Lindstedt P, Nilsson G, Steffes MW, Insulin Standardization Work Group. Toward standardization of insulin immunoassays. Clin Chem 2009; 55:1011-1018
4. Vølund A, Brange J, Drejer K, Jensen I, Markussen J, Ribel U, Sørensen AR, Schlichtkrull J. In vitro and in vivo potency of insulin analogues designed for clinical use. Diabet Med 1991;8:839-847